Palbociclib Combo Tops Chemo in High-Risk Breast Cancer ...Middle East

The Phase III PADMA trial showed that palbociclib plus endocrine therapy doubled progression-free survival compared with chemotherapy in high-risk HR+/HER2− metastatic breast cancer. Medscape Medical News

Hence then, the article about palbociclib combo tops chemo in high risk breast cancer was published today ( Monday 16/12/2024 - 12:46 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Palbociclib Combo Tops Chemo in High-Risk Breast Cancer )

Also on site :

• UCSD, San Diego State part of widespread attack on Canvas education platform
• Sacramento State caught in nationwide cyberattack targeting online learning platform
• Hackers irrumpen en Canvas y afectan a universidades en plena semana de exámenes